Altogether these observations suggest that activation of LXR or TSPO, by increasing the levels of neuroactive steroids in the sciatic nerve, exerts neuroprotective effects in diabetic neuropathy and consequently may represent an alternative to the direct treatment with neuroactive steroids. Here, TSPO is linked to diabetic neuropathy.